1 Min Read
Dec 19 (Reuters) - Glenmark Pharmaceuticals Ltd
* Says Glenmark expects to file 2025 ANDAs and launch 20 generic products annually in the U.S. Source text: bit.ly/2hLg0qA Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.